Analysed XENON PHARMACEUTICALS INC (XENE:NASDAQ) News Sources
Did Positive X-TOLE2 Data and a Major Cash Raise Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative?
11-05-2026
yahoo.com
A Look At Xenon Pharmaceuticals (XENE) Valuation After Phase 3 X TOLE2 Success And Extended Cash Runway
11-05-2026
yahoo.com
SCANBO® FEATURED IN GOVERNMENT OF BRITISH COLUMBIA'S 2026 LIFE SCIENCES ECOSYSTEM MAP
12-05-2026
yahoo.com
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
18-05-2026
fool.com
UPGUYS Founders Mat Rezaei and Ramin Behzadi Named 2026 EY Entrepreneur Of The Year® Pacific Region Finalists as Canada's Leading TRT Platform Scales Nationwide
09-06-2026
yahoo.com
Assessing Xenon Pharmaceuticals (XENE) Valuation After Recent Share Price Pullback And Modest Undervaluation Estimate
11-06-2026
yahoo.com
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-07-2026
yahoo.com
What is the current price of XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The current price of XENON PHARMACEUTICALS INC (XENE:NASDAQ) is $66.4.
XENON PHARMACEUTICALS INC (XENE:NASDAQ) absolute price change since previous trading day?
The absolute price change of XENON PHARMACEUTICALS INC (XENE:NASDAQ) since the previous trading day is $0.62.
XENON PHARMACEUTICALS INC (XENE:NASDAQ) percentage price change since previous trading day?
The percentage price change of XENON PHARMACEUTICALS INC (XENE:NASDAQ) since the previous trading day is 0.9425%.
What is the most recent average sentiment score for XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The most recent average sentiment score for XENON PHARMACEUTICALS INC (XENE:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for XENON PHARMACEUTICALS INC (XENE:NASDAQ)?
The most recent sentiment for XENON PHARMACEUTICALS INC (XENE:NASDAQ) is .
SEC-8K** Filing Available For XENON PHARMACEUTICALS INC (XENE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.